Inositol: tolerability and safety

Limits of adverse event data and specific groups studied.

Key points

  • In PCOS, data on inositol side effects are limited, and there is no reliable confirmation that digestive complaints occur less often than with metformin. When choosing a supplement, proven better tolerability should not be assumed. [1] See the evidence 1
  • In a small study of people with bipolar depression receiving lithium or valproate, symptoms worsened during inositol use; whether this was related to the supplement is unknown. Discuss it with a clinician if receiving such treatment. [2] See the evidence 1

Practical guide

Check the conclusions and whether they apply to your situation.

Tolerability was assessed in different groups and comparisons.

Key points

Why these conclusions

What is known about tolerability

In a review of PCOS trials, gastrointestinal adverse events occurred less often with myo-inositol than metformin in the main analysis; when restricted to studies at low risk of bias, the result was unstable. Adverse events were not reported in 23 of 29 trials. [1]

In a six-week study of 17 people with bipolar depression on lithium or valproate, depression worsened by more than 50% on HRSD in 2 of 9 in the inositol group; the abstract provides no comparable control count. Causation and risk frequency have not been established. [2]

In a study of 464 pregnant people with PCOS receiving myo-inositol 2 g and folic acid 0.2 mg twice daily, adverse events were reported by 6.9% versus 9.1% with folic acid alone (RR 0.76; 95% CI 0.40–1.45). This does not establish safety of all doses and forms during pregnancy. [3]

Rare adverse events and long-term inositol safety remain uncertain; absence of reports does not prove absence of risk. [1]

In a review of PCOS trials, gastrointestinal adverse events occurred less often with myo-inositol than metformin in the main analysis; when restricted to studies at low risk of bias, the result was unstable. Adverse events were not reported in 23 of 29 trials.

In a review of PCOS trials, gastrointestinal adverse events occurred less often with myo-inositol than metformin in the main analysis; when restricted to studies at low risk of bias, the result was unstable. Adverse events were not reported in 23 of 29 trials. [1]

In a six-week study of 17 people with bipolar depression on lithium or valproate, depression worsened by more than 50% on HRSD in 2 of 9 in the inositol group; the abstract provides no comparable control count. Causation and risk frequency have not been established.

In a six-week study of 17 people with bipolar depression on lithium or valproate, depression worsened by more than 50% on HRSD in 2 of 9 in the inositol group; the abstract provides no comparable control count. Causation and risk frequency have not been established. [2]

In a study of 464 pregnant people with PCOS receiving myo-inositol 2 g and folic acid 0.2 mg twice daily, adverse events were reported by 6.9% versus 9.1% with folic acid alone (RR 0.76; 95% CI 0.40–1.45). This does not establish safety of all doses and forms during pregnancy.

In a study of 464 pregnant people with PCOS receiving myo-inositol 2 g and folic acid 0.2 mg twice daily, adverse events were reported by 6.9% versus 9.1% with folic acid alone (RR 0.76; 95% CI 0.40–1.45). This does not establish safety of all doses and forms during pregnancy. [3]

Rare adverse events and long-term inositol safety remain uncertain; absence of reports does not prove absence of risk.

Rare adverse events and long-term inositol safety remain uncertain; absence of reports does not prove absence of risk. [1]

More details

When to discuss use

If being treated for bipolar disorder with lithium or valproate, discuss the supplement with a clinician; causation of worsening in the small study has not been established. [2]

Sources

  1. Inositol for Polycystic Ovary Syndrome: A Systematic Review and Meta-analysis to Inform the 2023 Update of the International Evidence-based PCOS Guidelines. https://pmc.ncbi.nlm.nih.gov/articles/PMC11099481/
  2. Inositol augmentation of lithium or valproate for bipolar depression. https://pubmed.ncbi.nlm.nih.gov/16542187/
  3. Myo-inositol Supplementation to Prevent Pregnancy Complications in Polycystic Ovary Syndrome: A Randomized Clinical Trial. https://jamanetwork.com/journals/jama/fullarticle/2838634

Methodology: Subpages evidence-led supplement pipeline v1

Ingredient overview: Inositol family